tiprankstipranks
pc:alveu

Alveus Therapeutics

Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases. The company focuses on programs designed for sustained efficacy, improved tolerability, and reduced treatment burden, including a bifunctional GIPR antagonist/GLP-1R agonist and an amylin-based portfolio spanning injectable and oral modalities.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$160M
Total Amount Raised$160M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$160M
Latest Funding Amount$160M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series A
$159.80M

Investors

Investor Name
Funding Round

Related News and Analysis